ZTS - Zoetis Inc - Ordinary Shares - Class A
Close
183.49
0.600 0.327%
Share volume: 2,328,499
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$182.89
0.60
0.33%
Fundamental analysis
81%
Profitability
87%
Dept financing
42%
Liquidity
75%
Performance
87%
Performance
5 Days
1.43%
1 Month
0.91%
3 Months
8.55%
6 Months
-7.75%
1 Year
-3.83%
2 Year
19.02%
Key data
Stock price
$183.49
DAY RANGE
$180.98 - $184.22
52 WEEK RANGE
$144.46 - $200.41
52 WEEK CHANGE
-$0.04
DIVIDEND
$0.432
EX-DIVIDEND DATE
07/18/2024
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Kristin Peck
Region: US
Website: https://www.zoetis.com/
Employees: 13,800
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.zoetis.com/
Employees: 13,800
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
Recent news